Biotech News
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
ir.serestherapeutics.com2026-05-12 11:09 EST
CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright 4th Annual BioConnect Investor Conference and will present a company overview at 3:30 p.m.